Join
Live feed
·
PRReleasevia Quantisnow
Scholar Rock Holding Corporation logo

Scholar Rock Reports Positive Phase 2 EMBRAZE Trial Results Demonstrating Statistically Significant Preservation of Lean Mass with Apitegromab During Tirzepatide-Induced Weight Loss

ByQuantisnow·Wall Street's wire, on your screen.
SRRK· Scholar Rock Holding Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SRRK (Scholar Rock Holding Corporation) and more on Quantisnow.